{
    "case_number": "CAC-UDRP-107098",
    "time_of_filling": "2024-11-28 09:11:36",
    "domain_names": [
        "novartisglobal.com"
    ],
    "case_administrator": "  Iveta Špiclová   (Czech Arbitration Court) (Case admin)",
    "complainant": [
        "Novartis AG"
    ],
    "complainant_representative": "Abion GmbH",
    "respondent": [
        "freibert peter (Healthcare)"
    ],
    "respondent_representative": null,
    "factual_background": "<p><span>FACTS ASSERTED BY THE COMPLAINANT AND NOT CONTESTED BY THE RESPONDENT:<\/span><\/p>\n<p><span>&nbsp;<\/span><\/p>\n<p><span>The Novartis Group is one of the biggest global pharmaceutical and healthcare groups. It provides solutions to address the evolving needs of patients worldwide by developing and delivering innovative medical treatments and drugs. The Complainant, Novartis AG, maintains headquarters in Switzerland and was created in 1996 through a merger of two other companies Ciba-Geigyand Sandoz. Complainant is the holding company of the Novartis Group.<\/span><\/p>\n<p><span>&nbsp;<\/span><\/p>\n<p><span>The Complainant&rsquo;s products are manufactured and sold in many regions worldwide including the United States of America, a country where it has an active presence through its subsidiaries and associated companies. Further, the Complainant owns a number of registrations, in several countries, for the trademark NOVARTIS listing a wide variety of goods and services in the fields of pharmaceuticals and healthcare.<\/span><\/p>\n<p><span>&nbsp;<\/span><\/p>\n<p>The disputed domain name was registered on October 29, ,2024 and resolves to an inactive registrar parking page.<\/p>",
    "other_legal_proceedings": "<p>The Panel is not aware of any other legal proceedings which are pending or decided and which relate to the disputed domain name.<\/p>",
    "no_response_filed": "<p>COMPLAINANT<\/p>\n<p><\/p>\n<p>Rights to the NOVARTIS trademark have been demonstrated by the submission of evidence from relevant trademark registration offices. and the disputed domain name is confusingly similar as it incorporates the entirety of the trademark and only adds the generic term \"global\" and the \".com\" TLD.<\/p>\n<p><\/p>\n<p>The Respondent has no rights or legitimate interest in the disputed domain name where it is not commonly known thereby and it is not making a bona fide offering of goods or service nor a legitimate noncommercial or fair use of the disputed domain name.<\/p>\n<p><\/p>\n<p>The disputed domain name was registered and is used in bad faith where it resolves only to a registrar parking page, it has associated MX records, and the Respondent failed to reply to a cease-and-desist letter sent to it by the Complainant's Representative.<\/p>\n<p><\/p>\n<p>RESPONDENT<\/p>\n<p><br \/>No administratively compliant Response has been filed.<\/p>",
    "rights": "<p>The Complainant has, to the satisfaction of the Panel, shown the disputed domain name is identical or confusingly similar to a trademark or service mark in which the Complainant has rights (within the meaning of paragraph 4(a)(i) of the Policy).<\/p>",
    "no_rights_or_legitimate_interests": "<p>The Complainant has, to the satisfaction of the Panel, shown the Respondent to have no rights or legitimate interests in respect of the disputed domain name (within the meaning of paragraph 4(a)(ii) of the Policy).<\/p>",
    "bad_faith": "<p>The Complainant has, to the satisfaction of the Panel, shown the disputed domain name has been registered and is being used in bad faith (within the meaning of paragraph 4(a)(iii) of the Policy).<\/p>",
    "procedural_factors": "<p>The Panel is satisfied that all procedural requirements under UDRP were met and there is no other reason why it would be inappropriate to provide a decision.<\/p>",
    "decision": "Accepted",
    "panelists": [
        "Steven Levy"
    ],
    "date_of_panel_decision": "2024-12-27 00:00:00",
    "informal_english_translation": "<p><span>The Complainant has submitted evidence of the following registrations of the NOVARTIS trademark in relation to a range of products and services relating to a range of pharmaceutical and healthcare products and services:<\/span><\/p>\n<p><span>- Swiss trademark registration No. 2P-427370, registered on July 1, 1996, in classes 1, 2, 3, 4, 5, 7, 8, 9, 10, 14, 16, 17,20, 28, 29, 30, 31, 32, 40, and 42;<\/span><\/p>\n<p><span>- International trademark registration No. 663765, registered on July 1, 1996, in classes 1, 2, 3, 4, 5, 7, 8, 9, 10, 14, 16,17, 20, 22, 28, 29, 30, 31, 32, 40, and 42;<\/span><\/p>\n<p><span>- International trademark registration No. 1349878, registered on November 29, 2016, in classes 9, 10, 41, 42, 44, and 45;<\/span><\/p>\n<p><span>- United States trademark registration No. 4986124, registered on June 28, 2016, in classes 5, 9, 10, 41, 42, and 44; and<\/span><\/p>\n<p>- United States trademark registration No. 6990442, registered on February 28, 2023, in class 5.<\/p>",
    "decision_domains": {
        "novartisglobal.com": "TRANSFERRED"
    },
    "panelist": null,
    "panellists_text": null
}